Evaluation the effect of blood platelet on androgenic hair loss
Phase 2
- Conditions
- Androgenetic alopecia.Androgenetic alopecia
- Registration Number
- IRCT2014062918210N2
- Lead Sponsor
- Vice Chancellor of Iran university of Medical science-Research committee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 120
Inclusion Criteria
androgenic alopecia Hamilton grade 2 and 3; 20-35 years old men;normal laboratory tests of TSH, CBC AND ferritin ; do not use oral finastride or topical minoxidil for the last 3 months.Exclusion criteria:another systemic or topical disease on the scalp;use of telogen effluvium drugs;nutritional disease;scarring alopecia)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Androgenetic alopecia. Timepoint: 3 months and 6months later. Method of measurement: Photography.
- Secondary Outcome Measures
Name Time Method Hair growing. Timepoint: 3months and 6 months later. Method of measurement: Photography.